Growing Healthcare Demand in the UAE: Third Largest Distributor AKI Visits Taiwan for Collaboration

As the healthcare market in the Middle East in continuously expanding, the United Arab Emirates (UAE) has emerged as a core market due to high demand and growth potential of healthcare. Al Khayyat Investments (AKI), the UAE’s third-largest healthcare distribution, will be visiting Taiwan in December to participate in the Healthcare+ Expo, seeking collaboration opportunities to introduce Taiwan’s innovative healthcare technologies to the Middle East market.

According to the Ministry of Economic Affairs, R.O.C., the UAE currently stands as the fourth-largest market for the medical devices in the Middle East and North Africa (MENA), leading in the first per capita healthcare spending. Over the next five years, the market is expected to grow at an average annual rate of 8.4%, with an estimated value surpassing $200 million. However, the UAE remains highly dependent on imports for medical devices, as local production is largely limited to disposable supplies and basic components. This gap between healthcare demand and local supply presents abundant opportunities for international suppliers.

During their visit to Taiwan, AKI is particularly interested in Taiwan's advancements in digital health, cell storage, and cancer diagnostics. The company aims to identify potential suppliers to enhance its product offerings and meet the increasing healthcare needs of the UAE and Middle East. For Taiwanese companies, collaborating with AKI offers a fast track to entering the Middle East market. With AKI's strong market resources and distribution network, Taiwanese innovations can seamlessly integrate into the local healthcare landscape, fostering new business opportunities and driving mutual success in medical technology (Medtech).

Al Khayyat Investments (AKI), founded in 1982, initially focused on the pharmaceutical industry and has since grown into a diversified enterprise with a market value in the billions of dollars. The company represents over 100 international brands, covering medical devices, pharmaceuticals, and healthcare products. Its business covers both public and private hospitals, clinics, and pharmacies throughout the Middle East, with a market coverage rate of 98%. As a leading brand in the Middle Eastern healthcare industry, AKI's strong market position and comprehensive product portfolio make it a key partner for healthcare institutions in the region. Each year, AKI supports the treatment of over 3.2 million patients and helps register more than 4,000 pharmaceutical products.

About Al Khayyat Investments

Al Khayyat Investments (AKI), founded in 1982, initially focused on the pharmaceutical industry and has since grown into a diversified enterprise with a market value in the billions of dollars. The company represents over 100 international brands, covering medical devices, pharmaceuticals, and healthcare products. Its business covers both public and private hospitals, clinics, and pharmacies throughout the Middle East, with a market coverage rate of 98%. As a leading brand in the Middle Eastern healthcare industry, AKI's strong market position and comprehensive product portfolio make it a key partner for healthcare institutions in the region. Each year, AKI supports the treatment of over 3.2 million patients and helps register more than 4,000 pharmaceutical products.

AKI's subsidiary, Bin Sina Pharmacy, is the first chain pharmacy in the UAE, with over 150 branches. It has a flagship store in Dubai Healthcare City, known for its prestigious medical institutions and teaching centers, as well as locations in popular spots like Dubai Mall and The Galleria Mall Abu Dhabi.



Also Want to Explore More Business Opportunities?
【Register for the 2024 Heathcare+ Expo Now to find the best partners! ▸】